Experienced in Primary Lymphoma of the Brain

Szu-min S. Hsieh

7 Chung Shan South Road, 
TPQ, TW 
Experienced in Primary Lymphoma of the Brain
7 Chung Shan South Road, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Szu-min Hsieh practices in Taiwan. Hsieh is rated as an Experienced expert by MediFind in the treatment of Primary Lymphoma of the Brain. Their top areas of expertise are Hepatitis A, HIV/AIDS, Hepatitis, and Syphilis.

Their clinical research consists of co-authoring 90 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Primary Lymphoma of the Brain.

Locations

7 Chung Shan South Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II, Prospective, Randomized, Double-Blind, Dose-Comparison, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901 in Elderly Adults
A Phase II, Prospective, Randomized, Double-Blind, Dose-Comparison, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901 in Elderly Adults
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Biological
Study Phase: Phase 2
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Biological
Study Drug: AdimrSC-2f Vaccine
Study Phase: Phase 1
A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901
A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901
A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Biological
Study Drugs: MVC-COV1901 Vaccine, CpG 1018 Adjuvant
Study Phase: Phase 1
View 3 Less Clinical Trials

90 Total Publications

Long-Term Evolution of Renal Function Among People with HIV who Received Tenofovir Alafenamide-Containing Antiretroviral Therapy.
Long-Term Evolution of Renal Function Among People with HIV who Received Tenofovir Alafenamide-Containing Antiretroviral Therapy.
Journal: Infectious diseases and therapy
Published: December 11, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hsieh's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile